Prof. David Pfister

Go Back

Urologist

  • University Hospital of Cologne
  • location Germany

After finishing medical school in November 2004 Dr Pfister started his residency in the Department of Urology at the University of Cologne. For his endoscopic training, he switched to the General Hospital in Weiden (Oberpfalz/Bavaria) between August 2006 and March 2007. After returning to Cologne Dr Pfister heightened my oncologic education under Prof. Heidenreich. The oncologic training consisted of two arms: medical and surgical oncology. In 2009 his education was augmented at the University Hospital of Aachen. In 2010 he passed his urologic board exam. Since 2011 Dr Pfister has been working as a staff urologist with main interests in castration-resistant prostate cancer and testicular cancer. In 2011 he passed the Charles Huggins grant, an educational grant at the Center for Prostate Disease Research in Maryland, USA. In 2012 Dr Pfister received an additional qualification in the systemic treatment of solid tumours and since that time he has organised and led the urological clinical trial centre. In 2012 Dr Pfister qualified as a Professor and became an Associate Professor in November 2012 for medical oncologic treatment in urological tumours. At the end of 2015 he became the Commissionary Leader of the Urologic Department of the University of Aachen. Since 2016 Dr Pfister has become the Deputy Director of the Department of Urology, Uro-oncology and Robot-Assisted Surgery, University Hospital of Cologne. Special interest is castration-resistant, radiation-resistant prostate cancer and testicular cancer.

Prof. David Pfister has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

AstraZeneca, Bayer, Merck, MSD, Janssen and Pfizer. 

Other programmes developed by Prof. David Pfister

Oncology 
Highlights of 2021 in GU Oncology

Prof. David Pfister takes a look at the highlights of 2021 from GU CONNECT, in particular, the new trials and practice-changing developments in prostate, urothelial and kidney cancer.

Experts
Prof. David Pfister
  • download Downloadable
    Resouces
  • clock 5 MIN
  • calendar Nov 2021

Educational programme supported by an independent medical education grant from Bayer
Oncology 
Immunotherapy in genitourinary tumors

Experts
Prof. Sandy Srinivas, Prof. David Pfister
  • download Downloadable
    Resouces
  • clock 5 MIN
  • calendar Oct 2021

Educational programme supported by an independent medical education grant from Bayer

Episode

5

of 5

episode
Oncology 
Update from ASCO GU 2018

Episode 5

Experts
Prof. David Pfister
  • download Downloadable
    Resouces
  • clock 5 MIN
  • calendar Oct 2021

Educational programme supported by an independent medical education grant from Bayer
  • download Downloadable
    Resouces
  • clock 5 MIN
  • calendar Oct 2021

Educational programme supported by an independent medical education grant from Bayer
e-learning Interactive e-learning
Oncology 
The SHARE Communication Framework for mCRPC: video, slides and e-learning

Experts
Assoc. Prof. Alicia Morgans, Prof. David Pfister, Assoc. Prof. Tanya Dorff
Endorsed by
UsToo
  • download Downloadable
    Resouces
  • clock 60 MIN
  • calendar Oct 2021

Educational programme supported by an independent medical education grant from Bayer
Oncology 
Experts Knowledge Share: Managing nmCRPC and new imaging modalities

GU CONNECT has produced an interactive e-learning, slide set and video about current opinions on managing nmCRPC and the implications of new imaging modalities.

Experts
Prof. David Pfister, Assoc. Prof. Alicia Morgans
  • download Downloadable
    Resouces
  • clock 60 MIN
  • calendar Sep 2021

Educational programme supported by an independent medical education grant from Bayer